← Human Trials & Peer-Reviewed Studies

Efficacy of high zinc biofortified wheat in improvement of micronutrient status, and prevention of morbidity among preschool children and women - a double masked, randomized, controlled trial.

Plain-language guide to PMID 30219062 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 6005 participants.

Key Facts

PMID
30219062
Journal
Nutrition journal
Year
2018
Study type
Randomized Controlled Trial
Authors
Sazawal S et al. (8 authors)
DOI
10.1186/s12937-018-0391-5

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

Agronomic approaches such as application of Zn fertilizers to soil and/or foliar spray seem to be a practical tool for Zn biofortification of wheat.

Http://ctri.nic.in/Clinicaltrials/, CTRI/2014/04/004527, Registered April 7, 2014.

Who Took Part

According to the abstract, 6005 participants were involved.

PubMed indexes the participants as young children, children, teenagers, young adults, adults and middle-aged adults, both men and women.

How the Study Was Run

The design is described as randomized and double-blind.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

Baseline and endline blood samples were obtained for assessing hematological markers; zinc status and data on compliance and morbidity were collected.

What Was Measured

PubMed files the paper under topics including Food, Fortified, India, Malnutrition, Micronutrients, Nutritional Status, Triticum and Zinc.

Author keywords: Biofortification, Children, Morbidity, Plasma zinc and Woman of child-bearing age.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 6005 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2018 (Nutrition journal), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.